Tompkins Financial Corp Amgen Inc Transaction History

Tompkins Financial Corp

$1.04 Billion
Q3 2024

A detailed history of Tompkins Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Tompkins Financial Corp holds 32,411 shares of AMGN stock, worth $9.33 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

32,411

Previous 32,179 0.72%

Holding current value

$9.33 Million

Previous $10.1 Million 3.87%

% of portfolio

1.01%

Previous 1.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$309.38 - $337.38 $71,776 - $78,272	232 Added 0.72%	32,411 $10.4 Million
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $74,621 - $90,684	-284 Reduced 0.87%	32,179 $10.1 Million
Q1 2024 Apr 08, 2024	SELL	$268.87 - $324.56 $44,632 - $53,876	-166 Reduced 0.51%	32,463 $9.23 Million
Q4 2023 Jan 08, 2024	BUY	$255.7 - $288.46 $592,712 - $668,650	2,318 Added 7.65%	32,629 $9.4 Million
Q3 2023 Nov 20, 2023	BUY	$218.65 - $271.46 $631,679 - $784,247	2,889 Added 10.54%	30,311 $8.15 Million
Q2 2023 Jul 12, 2023	SELL	$214.27 - $253.37 $72,851 - $86,145	-340 Reduced 1.22%	27,422 $6.09 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $184,470 - $224,838	-817 Reduced 2.86%	27,762 $6.71 Million
Q4 2022 Jan 06, 2023	SELL	$229.03 - $291.01 $129,860 - $165,002	-567 Reduced 1.95%	28,579 $7.51 Million
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $35,689 - $40,250	159 Added 0.55%	29,146 $6.57 Million
Q2 2022 Jul 14, 2022	BUY	$230.71 - $256.74 $161,266 - $179,461	699 Added 2.47%	28,987 $7.05 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $396,220 - $438,323	1,807 Added 6.82%	28,288 $6.84 Million
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $100,036 - $114,482	503 Added 1.94%	26,481 $5.96 Million
Q3 2021 Oct 22, 2021	BUY	$212.27 - $248.7 $115,899 - $135,790	546 Added 2.15%	25,978 $5.52 Million
Q1 2021 Jun 09, 2021	BUY	$221.91 - $258.6 $113,617 - $132,403	512 Added 2.05%	25,432 $6.33 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $2.64 Million - $3.14 Million	12,200 Added 95.91%	24,920 $5.73 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $2.25 Million - $2.68 Million	-10,385 Reduced 44.95%	12,720 $2.58 Million
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $48,103 - $53,494	205 Added 0.9%	23,105 $5.87 Million
Q2 2020 Jul 29, 2020	BUY	$197.81 - $242.74 $159,632 - $195,891	807 Added 3.65%	22,900 $5.4 Million
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $41,732 - $55,349	-229 Reduced 1.03%	22,093 $4.48 Million
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $126,581 - $162,700	669 Added 3.09%	22,322 $5.38 Million
Q3 2019 Oct 17, 2019	SELL	$174.11 - $208.62 $12,884 - $15,437	-74 Reduced 0.34%	21,653 $4.19 Million
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $201,373 - $236,055	1,208 Added 5.89%	21,727 $4 Million
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $235,673 - $265,655	1,303 Added 6.78%	20,519 $3.9 Million
Q1 2019 Apr 17, 2019	SELL	$180.87 - $203.88 $112,501 - $126,813	-622 Reduced 3.14%	19,216 $3.98 Million
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $110,964 - $129,531	622 Added 3.24%	19,838 $3.86 Million
Q3 2018 Oct 18, 2018	BUY	$185.29 - $208.89 $92,645 - $104,445	500 Added 2.67%	19,216 $3.98 Million
Q2 2018 Jul 18, 2018	BUY	$166.05 - $186.51 $26,235 - $29,468	158 Added 0.85%	18,716 $3.46 Million
Q1 2018 Apr 26, 2018	BUY	$169.43 - $198.0 $940,505 - $1.1 Million	5,551 Added 42.68%	18,558 $3.16 Million
Q4 2017 Jan 24, 2018	SELL	$168.79 - $188.59 $20,254 - $22,630	-120 Reduced 0.91%	13,007 $2.26 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $2.2 Million - $2.51 Million	13,127	13,127 $2.45 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.

Account

Tompkins Financial Corp Amgen Inc Transaction History